Loading…
Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges
The development and progression of cancer, a collection of diseases with complex genetic architectures, is facilitated by the interplay of multiple etiological factors. This complexity challenges the traditional single-platform study design and calls for an integrated approach to data analysis. Howe...
Saved in:
Published in: | Frontiers in genetics 2016-02, Vol.7, p.2-2 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c462t-909588970149a22b308dca62ef2e4cb827e834a4634eaad779bf2a49dc1f67f53 |
---|---|
cites | cdi_FETCH-LOGICAL-c462t-909588970149a22b308dca62ef2e4cb827e834a4634eaad779bf2a49dc1f67f53 |
container_end_page | 2 |
container_issue | |
container_start_page | 2 |
container_title | Frontiers in genetics |
container_volume | 7 |
creator | Thingholm, Louise B Andersen, Lars Makalic, Enes Southey, Melissa C Thomassen, Mads Hansen, Lise Lotte |
description | The development and progression of cancer, a collection of diseases with complex genetic architectures, is facilitated by the interplay of multiple etiological factors. This complexity challenges the traditional single-platform study design and calls for an integrated approach to data analysis. However, integration of heterogeneous measurements of biological variation is a non-trivial exercise due to the diversity of the human genome and the variety of output data formats and genome coverage obtained from the commonly used molecular platforms. This review article will provide an introduction to integration strategies used for analyzing genetic risk factors for cancer. We critically examine the ability of these strategies to handle the complexity of the human genome and also accommodate information about the biological and functional interactions between the elements that have been measured-making the assessment of disease risk against a composite genomic factor possible. The focus of this review is to provide an overview and introduction to the main strategies and to discuss where there is a need for further development. |
doi_str_mv | 10.3389/fgene.2016.00002 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_167a4a5945254b15a129adc9269f2fef</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_167a4a5945254b15a129adc9269f2fef</doaj_id><sourcerecordid>1765112915</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-909588970149a22b308dca62ef2e4cb827e834a4634eaad779bf2a49dc1f67f53</originalsourceid><addsrcrecordid>eNpVUk1v3CAQtapWTZTm3lPFsYfuFjDG0EOl1WqTrBSph35c0RgGL5EXb8FbNYf-99reJEq48Jg382aAVxTvGV2WpdKffYsRl5wyuaTj4q-KcyalWCjK2etn-Ky4zPluShG6LEvxtjjjUtWUKnZe_Ps-JBiwDZiJ7xPZxvEwRRxZRejuc8ik9-R6bDUE-4lsDqF9xBDdTJDN30PCnEMfyS9IAYYJhUjWEC2mL2Tl3MzHlgw7JOsddB3GFvO74o2HLuPlw35R_Lza_FjfLG6_XW_Xq9uFFZIPC011pZSuKRMaOG9KqpwFydFzFLZRvEZVChCyFAjg6lo3noPQzjIva1-VF8X2pOt6uDOHFPaQ7k0PwcyBPrUG0ninDg2TNQiotKh4JRpWAeManNVcas89-lHr60nrcGz26CzG8QW7F6IvmRh2pu3_GFELqrQaBT4-CKT-9xHzYPYhW-w6iNgfs2G1rNjYlU1z01OqTX3OCf1TG0bNZAIzm8BMJjCzCcaSD8_Heyp4_PLyP1wor1E</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765112915</pqid></control><display><type>article</type><title>Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges</title><source>PubMed Central (Open access)</source><creator>Thingholm, Louise B ; Andersen, Lars ; Makalic, Enes ; Southey, Melissa C ; Thomassen, Mads ; Hansen, Lise Lotte</creator><creatorcontrib>Thingholm, Louise B ; Andersen, Lars ; Makalic, Enes ; Southey, Melissa C ; Thomassen, Mads ; Hansen, Lise Lotte</creatorcontrib><description>The development and progression of cancer, a collection of diseases with complex genetic architectures, is facilitated by the interplay of multiple etiological factors. This complexity challenges the traditional single-platform study design and calls for an integrated approach to data analysis. However, integration of heterogeneous measurements of biological variation is a non-trivial exercise due to the diversity of the human genome and the variety of output data formats and genome coverage obtained from the commonly used molecular platforms. This review article will provide an introduction to integration strategies used for analyzing genetic risk factors for cancer. We critically examine the ability of these strategies to handle the complexity of the human genome and also accommodate information about the biological and functional interactions between the elements that have been measured-making the assessment of disease risk against a composite genomic factor possible. The focus of this review is to provide an overview and introduction to the main strategies and to discuss where there is a need for further development.</description><identifier>ISSN: 1664-8021</identifier><identifier>EISSN: 1664-8021</identifier><identifier>DOI: 10.3389/fgene.2016.00002</identifier><identifier>PMID: 26870081</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Array data ; Cancer ; DNA Methylation ; Gene expression ; Genetics ; Integrated analysis ; massive parallel sequencing (MPS)</subject><ispartof>Frontiers in genetics, 2016-02, Vol.7, p.2-2</ispartof><rights>Copyright © 2016 Thingholm, Andersen, Makalic, Southey, Thomassen and Hansen. 2016 Thingholm, Andersen, Makalic, Southey, Thomassen and Hansen</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-909588970149a22b308dca62ef2e4cb827e834a4634eaad779bf2a49dc1f67f53</citedby><cites>FETCH-LOGICAL-c462t-909588970149a22b308dca62ef2e4cb827e834a4634eaad779bf2a49dc1f67f53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740898/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740898/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26870081$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thingholm, Louise B</creatorcontrib><creatorcontrib>Andersen, Lars</creatorcontrib><creatorcontrib>Makalic, Enes</creatorcontrib><creatorcontrib>Southey, Melissa C</creatorcontrib><creatorcontrib>Thomassen, Mads</creatorcontrib><creatorcontrib>Hansen, Lise Lotte</creatorcontrib><title>Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges</title><title>Frontiers in genetics</title><addtitle>Front Genet</addtitle><description>The development and progression of cancer, a collection of diseases with complex genetic architectures, is facilitated by the interplay of multiple etiological factors. This complexity challenges the traditional single-platform study design and calls for an integrated approach to data analysis. However, integration of heterogeneous measurements of biological variation is a non-trivial exercise due to the diversity of the human genome and the variety of output data formats and genome coverage obtained from the commonly used molecular platforms. This review article will provide an introduction to integration strategies used for analyzing genetic risk factors for cancer. We critically examine the ability of these strategies to handle the complexity of the human genome and also accommodate information about the biological and functional interactions between the elements that have been measured-making the assessment of disease risk against a composite genomic factor possible. The focus of this review is to provide an overview and introduction to the main strategies and to discuss where there is a need for further development.</description><subject>Array data</subject><subject>Cancer</subject><subject>DNA Methylation</subject><subject>Gene expression</subject><subject>Genetics</subject><subject>Integrated analysis</subject><subject>massive parallel sequencing (MPS)</subject><issn>1664-8021</issn><issn>1664-8021</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVUk1v3CAQtapWTZTm3lPFsYfuFjDG0EOl1WqTrBSph35c0RgGL5EXb8FbNYf-99reJEq48Jg382aAVxTvGV2WpdKffYsRl5wyuaTj4q-KcyalWCjK2etn-Ky4zPluShG6LEvxtjjjUtWUKnZe_Ps-JBiwDZiJ7xPZxvEwRRxZRejuc8ik9-R6bDUE-4lsDqF9xBDdTJDN30PCnEMfyS9IAYYJhUjWEC2mL2Tl3MzHlgw7JOsddB3GFvO74o2HLuPlw35R_Lza_FjfLG6_XW_Xq9uFFZIPC011pZSuKRMaOG9KqpwFydFzFLZRvEZVChCyFAjg6lo3noPQzjIva1-VF8X2pOt6uDOHFPaQ7k0PwcyBPrUG0ninDg2TNQiotKh4JRpWAeManNVcas89-lHr60nrcGz26CzG8QW7F6IvmRh2pu3_GFELqrQaBT4-CKT-9xHzYPYhW-w6iNgfs2G1rNjYlU1z01OqTX3OCf1TG0bNZAIzm8BMJjCzCcaSD8_Heyp4_PLyP1wor1E</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Thingholm, Louise B</creator><creator>Andersen, Lars</creator><creator>Makalic, Enes</creator><creator>Southey, Melissa C</creator><creator>Thomassen, Mads</creator><creator>Hansen, Lise Lotte</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160201</creationdate><title>Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges</title><author>Thingholm, Louise B ; Andersen, Lars ; Makalic, Enes ; Southey, Melissa C ; Thomassen, Mads ; Hansen, Lise Lotte</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-909588970149a22b308dca62ef2e4cb827e834a4634eaad779bf2a49dc1f67f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Array data</topic><topic>Cancer</topic><topic>DNA Methylation</topic><topic>Gene expression</topic><topic>Genetics</topic><topic>Integrated analysis</topic><topic>massive parallel sequencing (MPS)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thingholm, Louise B</creatorcontrib><creatorcontrib>Andersen, Lars</creatorcontrib><creatorcontrib>Makalic, Enes</creatorcontrib><creatorcontrib>Southey, Melissa C</creatorcontrib><creatorcontrib>Thomassen, Mads</creatorcontrib><creatorcontrib>Hansen, Lise Lotte</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thingholm, Louise B</au><au>Andersen, Lars</au><au>Makalic, Enes</au><au>Southey, Melissa C</au><au>Thomassen, Mads</au><au>Hansen, Lise Lotte</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges</atitle><jtitle>Frontiers in genetics</jtitle><addtitle>Front Genet</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>7</volume><spage>2</spage><epage>2</epage><pages>2-2</pages><issn>1664-8021</issn><eissn>1664-8021</eissn><abstract>The development and progression of cancer, a collection of diseases with complex genetic architectures, is facilitated by the interplay of multiple etiological factors. This complexity challenges the traditional single-platform study design and calls for an integrated approach to data analysis. However, integration of heterogeneous measurements of biological variation is a non-trivial exercise due to the diversity of the human genome and the variety of output data formats and genome coverage obtained from the commonly used molecular platforms. This review article will provide an introduction to integration strategies used for analyzing genetic risk factors for cancer. We critically examine the ability of these strategies to handle the complexity of the human genome and also accommodate information about the biological and functional interactions between the elements that have been measured-making the assessment of disease risk against a composite genomic factor possible. The focus of this review is to provide an overview and introduction to the main strategies and to discuss where there is a need for further development.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>26870081</pmid><doi>10.3389/fgene.2016.00002</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-8021 |
ispartof | Frontiers in genetics, 2016-02, Vol.7, p.2-2 |
issn | 1664-8021 1664-8021 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_167a4a5945254b15a129adc9269f2fef |
source | PubMed Central (Open access) |
subjects | Array data Cancer DNA Methylation Gene expression Genetics Integrated analysis massive parallel sequencing (MPS) |
title | Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A00%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strategies%20for%20Integrated%20Analysis%20of%20Genetic,%20Epigenetic,%20and%20Gene%20Expression%20Variation%20in%20Cancer:%20Addressing%20the%20Challenges&rft.jtitle=Frontiers%20in%20genetics&rft.au=Thingholm,%20Louise%20B&rft.date=2016-02-01&rft.volume=7&rft.spage=2&rft.epage=2&rft.pages=2-2&rft.issn=1664-8021&rft.eissn=1664-8021&rft_id=info:doi/10.3389/fgene.2016.00002&rft_dat=%3Cproquest_doaj_%3E1765112915%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-909588970149a22b308dca62ef2e4cb827e834a4634eaad779bf2a49dc1f67f53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1765112915&rft_id=info:pmid/26870081&rfr_iscdi=true |